DC vaccination was capable of promoting secretion of Th1 cytokines, as well as of significantly increased the number of peripheral blood NK cells and leding to tumor-specific CD8+ T-cell expansion and further differentiation into IFN-γ-producing effector cells (Qi et al., 2012). This evidence concerns the gene CD8A and neoplasm.